Not long ago, the right experts for medical affairs programs used to be those who published the most or were particularly prolific speakers at medical congresses and conferences. In other words, the loudest academic or scientific voices in the industry.
While that perception persists for some medical affairs teams and life science leadership, many have discovered that advancements in network analytics can open the door to experts across the globe – specifically, the experts doing the work most relevant to the stage and disease state of a product’s development and commercial pathway. At different points, medical affairs teams need different expertise to generate the most strategic insights. At times those may be treating physicians, but at other times these insights may come from researchers, referrers, and other niche experts.
Disconnected data sources and list-based approaches have traditionally hindered the discovery of these experts for medical affairs teams, leaving insight gaps. In the first episode of this tech-centered series on the MAPS Elevate podcast channel, learn how emerging technology is helping teams be more effective in their KOL identification efforts.
Listen as Within3 CEO Lance Hill and Vice President of Product Marketing Samantha Veeck talk with MAPS’ Garth Sundem about two critical innovations: widening data sets and the application of network analytics. Evidence suggests medical affairs teams that don’t adopt these technologies may be assigning resources to incorrect experts 20 percent of the time – or one of every five meetings. Teams that are applying these tools can reduce that number to five percent, which can account for a significant competitive advantage.